Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2015

View Archived Issues

Yabao Pharmaceutical and Primary Peptides to collaborate on peptide therapeutics for stroke

AntriaBio confirms new product candidate, AB-301, for type 2 diabetes

EnGeneIC to begin U.S. phase I study of (EGFR)-EDV-dox

Otsuka launches Olanedine antiseptic

Aerie Pharmaceuticals reports phase III efficacy data for Rhopressa

New mutation in LYRM7 gene associated with complex III deficiency

Nurix collaborates with Celgene on therapies to modulate protein homeostasis

AB Science's masitinib receives FDA orphan drug designation for gastric cancer

Ajinomoto patents MOGAT2 inhibitors

Arizona State University discloses RXR agonists

Toray Industries reports development of ROR-gamma antagonists

Memorial Sloan Kettering and Illumina collaborate on circulating tumor DNA

British scientists develop CDK7 inhibitors

Janssen Pharmaceutica synthesizes CB1 inverse agonists

Mitobridge signs sponsored research agreement for its PPARdelta modulators

New malaria vaccine trial shows lack of efficacy

Proof-of-concept study shows promise of novel antimalarial KAF-156

Amgen agrees to acquire TA-8995 developer Dezima Pharma

Prolyl oligopeptidase inhibitor shows promise for cognitive deficit associated with schizophrenia

Ignyta starts phase I trial of RXDX-107 in patients with solid tumors

Dimension Therapeutics' hemophilia B gene therapy receives FDA fast track designation

Phase I/IIa results presented for ChAd-EBO-Z Ebola vaccine

FDA grants orphan drug designation to sephin-1 for the treatment of Charcot-Marie-Tooth disease

Hypoglycemia may be detected by analyzing exhaled breath

FDA awards fast track designation to Can-Fite's CF-102 for hepatocellular carcinoma

Ventrix initiates phase I trial of VentriGel in patients following myocardial infarction

FDA approves Vraylar for bipolar disorder and schizophrenia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...